...
首页> 外文期刊>JCO oncology practice. >Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer
【24h】

Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer

机译:评估前列腺癌男性基因测试主流模型

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE To identify the approximately 12% with inherited cancer predisposition, all men with metastatic prostate cancer (mPC) should be offered germline genetic testing. This guides treatment choices and impacts cancer prevention in the family. Limited genetic services globally present a barrier to testing. This study tested a potential solution, "mainstreaming," where counseling and testing are performed by the patient's oncologist.
机译:目的是确定大约12%的遗传性癌症易感性,所有患有前列腺转移性癌症(MPC)的男性均应提供种系基因检测。 这指导了治疗选择并影响家庭预防癌症。 有限的遗传服务在全球范围内呈现出测试的障碍。 这项研究测试了一种潜在的解决方案“主流化”,该解决方案由患者的肿瘤学家进行咨询和测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
  • 1. PROSTATE CANCER GEN. [P] . 外国专利: ES2190925T3 . 2003-09-01

    机译:prostate cancer gen.

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号